Ocular manifestations of systemic lupus erythematosus

Current Opinion in Ophthalmology

Volumn 19, Issue 6, 2008, Pages 512-518

  Davies, John B ^a,b   Rao, Prabakar Kumar ^a,b  

^a BARNES RETINA INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Antiphospholipid antibody; Dry eye; Immunosuppressive therapy; Retinopathy; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; EPRATUZUMAB; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RITUXIMAB;

CORTICOSTEROID THERAPY; EYE DISEASE; EYE TOXICITY; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; PATHOGENESIS; PRIORITY JOURNAL; RETINA DISEASE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL IMPAIRMENT;

EYE DISEASES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 56249119931     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283126d34     Document Type: Review

References (104)

1. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008; 358:929-939. This article highlights the recent advances in our understanding of the immunological mechanisms of SLE. Potential new treatment strategies are discussed in this context.
2. D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 2007; 369:587-596. This is an important review of the epidemiology, pathogenesis, and clinical course of SLE. Special attention is given to the antiphospholipid antibody syndrome as well as other systemic manifestations. The authors include a clear discussion of recent advances in immunology and new therapeutic modalities.
3. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-1277.
4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
5. Walport MJ. Complement and systemic lupus erythematosus. Arthritis Res 2002; 4 (Suppl 3):S279-S293.
6. Gross AJ, Hochberg D, Rand WM, et al. EBV and systemic lupus erythematosus: a new perspective. J Immunol 2005; 174:6599-6607.
7. Zhu B, Chen N, Lin Y, et al. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 2007; 22:1933-1942. The authors present a meta-analysis of randomized controlled clinical trials comparing mycophenolate mofetil to cyclophosphamide and azathioprine for the treatment of lupus nephritis. They found that mycophenolate mofetil had a higher efficacy in inducing remission with fewer side effects compared with cyclophosphamide. Additionally, mycophenolate mofetil may be an alternative to azathioprine in maintenance therapy for lupus nephritis.
8. Miescher PA. Treatment of systemic lupus erythematosus. Springer Semin Immunopathol 1986; 9:271-282.
9. Papadaki TG, Zacharopoulos IP, Papaliodis G, et al. Plasmapheresis for lupus retinal vasculitis. Arch Ophthalmol 2006; 124:1654-1656.
10. Anolik J, Sanz I, Looney RJ. B cell depletion therapy in systemic lupus erythematosus. Curr Rheumatol Rep 2003; 5:350-356.
11. Leandro MJ, Edwards JC, Cambridge G, et al. An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum 2002; 46:2673-2677.
12. Camous L, Melander C, Vallet M, et al. Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy. Am J Kidney Dis 2008; 52:346-352. Rituximab was used for induction and maintenance therapy to achieve complete remission of lupus nephritis. Treatment with rituximab may be advantageous as compared with cyclophosphamide regimens that are associated with increased morbidity and mortality.
13. Dorner T, Kaufmann J, Wegener WA, et al. Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus. Arthritis Res Ther 2006; 8:R74.
14. Alarcon-Segovia D, Tumlin JA, Furie RA, et al. UP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study. Arthritis Rheum 2003; 48:442-454.
15. Llorente L, Richaud-Patin Y, Garcia-Padilla C, et al. Clinical and biologic effects of antiinterleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 2000; 43:1790-1800.
16. Aringer M, Graninger WB, Steiner G, et al. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum 2004; 50:3161-3169.
17. Klejnberg T, Moraes Junior HV. Ophthalmological alterations in outpatients with systemic lupus erythematosus. Arq Bras Oftalmol 2006; 69:233-237.
18. Prabu A, Marshall T, Gordon C, et al. Use of patient age and anti-Ro/La antibody status to determine the probability of patients with systemic lupus erythematosus and sicca symptoms fulfilling criteria for secondary Sjogren's syndrome. Rheumatology (Oxford) 2003; 42:189-191.
19. Gilboe IM, Kvien TK, Uhlig T, et al. Sicca symptoms and secondary Sjogren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis 2001; 60:1103-1109.
20. Jensen JL, Bergem HO, Gilboe IM, et al. Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus. J Oral Pathol Med 1999; 28:317-322.
21. Varga JH, Wolf TC. Bilateral transient keratoendotheliitis associated with systemic lupus erythematosus. Ann Ophthalmol 1993; 25:222-223.
22. Adan CB, Trevisani VF, Vasconcellos M, et al. Bilateral deep keratitis caused by systemic lupus erythematosus. Cornea 2004; 23:207-209.
23. Alio JL, Artola A, Belda JI, et al. LASIK in patients with rheumatic diseases: a pilot study. Ophthalmology 2005; 112:1948-1954.
24. Smith RJ, Maloney RK. Laser in situ keratomileusis in patients with autoimmune diseases. J Cataract Refract Surg 2006; 32:1292-1295.
25. Cua IY, Repose JS. Late corneal scarring after photorefractive keratectomy concurrent with development of systemic lupus erythematosus. J Refract Surg 2002; 18:750-752.
26. Li Y, Li HY. Analysis of clinical characteristics and risk factors of corneal melting after laser in situ keratomileusis. Zhonghua Yan Ke Za Zhi 2005; 41:330-334.
27. Seiler T, Wollensak J. Complications of laser keratomileusis with the excimer laser (193nm). Klin Monatsbl Augenheilkd 1992; 200:648-653.
28. Montehermoso A, Cervera R, Font J, et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum 1999; 28:326-332.
29. Stafford-Brady FJ, Urowitz MB, Gladman DD, et al. Lupus retinopathy: patterns, associations, and prognosis. Arthritis Rheum 1988; 31:1105-1110.
30. Klinkhoff AV, Beattie CW, Chalmers A. Retinopathy in systemic lupus erythematosus: relationship to disease activity. Arthritis Rheum 1986; 29: 1152-1156.
31. Ushiyama O, Ushiyama K, Koarada S, et al. Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis 2000; 59:705-708.
32. Gold DH, Morris DA, Henkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 1972; 56:800-804.
33. Lanham JG, Barrie T, Kohner EM, et al. SLE retinopathy: evaluation by fluorescein angiography. Ann Rheum Dis 1982; 41:473-478.
34. Jabs DA, Fine SL, Hochberg MC, et al. Severe retinal vaso-occlusive disease in systemic lupus etythematous. Arch Ophthalmol 1986; 104: 558-563.
35. Au A, O'Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Experiment Ophthalmol 2004; 32:87-100.
36. Read RW, Chong LP, Rao NA. Occlusive retinal vasculitis associated with systemic lupus erythematosus. Arch Ophthalmol 2000; 118:588-589.
37. Leibovitch I, Goldstein M, Loewenstein A, et al. Combined central retinal artery and vein occlusion in a patient with systemic lupus erythematosus. Rheumatology (Oxford) 2001; 40:1195-1196.
38. Durukan AH, Akar Y, Bayraktar MZ, et al. Combined retinal artery and vein occlusion in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Can J Ophthalmol 2005; 40:87-89.
39. Fitzpatrick EP, Chesen N, Rahn EK. The lupus anticoagulant and retinal vasoocclusive disease. Ann Ophthalmol 1990; 22:148-152.
40. Mendrinos E, Mavrakanas N, Kiel R, et al. Bilateral combined central retinal artery and vein occlusion in systemic lupus erythematosus resulting in complete blindness. Eye 2008 [Epub ahead of print]. This report of bilateral, combined central retinal artery and vein occlusions high-lights the profound visual loss that may result from SLE.
41. Abu el-Asrar AM, Naddaf HO, Mitwali A. Choroidopathy in a case of systemic lupus erythematosus. Lupus 1995; 4:496-497.
42. Benitez del Castillo JM, Castillo A, Fernandez-Cruz A, et al. Persistent choroidopathy in systemic lupus erythematosus. Doc Ophthalmol 1994; 88:175-178.
43. Hannouche D, Korobelnik JF, Cochereau I, et al. Systemic lupus erythematosus with choroidopathy and serous retinal detachment. Int Ophthalmol 1995; 19:125-127.
44. Gharbiya M, Bozzoni-Pantaleoni F, Augello F, et al. Indocyanine green angiographic findings in systemic lupus erythematosus choroidopathy. Am J Ophthalmol 2002; 134:286-290.
45. Lavina AM, Agarwal A, Hunyor A, et al. Lupus choroidopathy and choroidal effusions. Retina 2002; 22:643-647.
46. Nguyen QD, Uy HS, Akpek EK, et al. Choroidopathy of systemic lupus erythematosus. Lupus 2000; 9:288-298.
47. Wisotsky BJ, Magat-Gordon CB, Puklin JE. Angle-closure glaucoma as an initial presentation of systemic lupus erythematosus. Ophthalmology 1998; 105:1170-1172.
48. Sivaraj RR, Durrani OM, Denniston AK, et al. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 2007; 46:1757-1762.
49. Lin YC, Wang AG, Yen MY. Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review. Acta Ophthalmol 2008 [Epub ahead of print].
50. Birnbaum J, Kerr D. Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus. Nat Clin Pract Rheumatol 2008; 4:381-386.
51. Fernandez Fernandez FJ, Fernandez Larranaga JR, Ferez Fernandez S, et al. Optic neuritis as first manifestation of systemic lupus erythematosus. An Med Interna 2004; 21:366.
52. Im CY, Kim SS, Kim HK. Bilateral optic neuritis as first manifestation of systemic lupus erythematosus. Korean J Ophthalmol 2002; 16:52-58.
53. Giorgi D, Balacco Gabrieli C. Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis. Clin Rheumatol 1999; 18:124-131.
54. Ahmadieh H, Roodpeyma S, Azarmina M, et al. Bilateral simultaneous optic neuritis in childhood systemic lupus erythematosus: a case report. J Neuroophthalmol 1994; 14:84-86.
55. Appolloni R, Formicola R, Scurci M, et al. Lupus anticoagulant and bilateral optic disc edema: a case report. Ann Ophthalmol 1991; 23:312-317.
56. Jabs DA, Miller NR, Newman SA, et al. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 1986; 104:564-568.
57. Smith CA, Pinals RS. Optic neuritis in systemic lupus erythematosus. J Rheumatol 1982; 9:963-966.
58. Cinefro RJ, Frenkel M. Systemic lupus erythematosus presenting as optic neuritis. Ann Ophthalmol 1978; 10:559-563.
59. Hackett ER, Martinez RD, Larson PF, et al. Optic neuritis in systemic lupus erythematosus. Arch Neurol 1974; 31:9-11.
60. Kenik JG, Krohn K, Kelly RB, et al. Transverse myelitis and optic neuritis in systemic lupus erythematosus: a case report with magnetic resonance imaging findings. Arthritis Rheum 1987; 30:947-950.
61. Oppenheimer S, Hoffbrand BI. Optic neuritis and myelopathy in systemic lupus erythematosus. Can J Neurol Sci 1986; 13:129-132.
62. Togashi M, Numata K, Yamamoto S, et al. Anterior ischemic optic neuropathy in a patient with positive antinuclear antibody and lupus anticoagulant findings. Ophthalmologica 1996; 210:132-135.
63. Cordeiro MF, Lloyd ME, Spalton DJ, et al. Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an antiphospholipid positive patient with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 1994; 57: 1142-1143.
64. Massin M, Berche C, Ullern M, et al. Acute anterior ischemic optic neuropathy disclosing disseminated lupus erythematosus. Ophtalmologie 1987; 1:61-63.
65. Siatkowski RM, Scott IU, Verm AM, et al. Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus. J Neuroophthalmol 2001; 21:193-198.
66. Frohman LP, Frieman BJ, Wolansky L. Reversible blindness resulting from optic chiasmitis secondary to systemic lupus erythematosus. J Neuroophthalmol 2001; 21:18-21.
67. Galindo-Rodriguez G, Avina-Zubieta JA, Pizarro S, et al. Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial. Am J Med 1999; 106:65-69.
68. Keane JR. Eye movement abnormalities in systemic lupus erythematosus. Arch Neurol 1995; 52:1145-1149.
69. Rheu CW, Lee SI, Yoo WH. A catastrophic-onset longitudinal myelitis accompanied by bilateral internuclear ophthalmoplegia in a patient with systemic lupus erythematosus. J Korean Med Sci 2005; 20:1085-1088.
70. Abel MP, Murphy FT, Enzenauer RJ, et al. Internuclear ophthalmoplegia (INO): an unusual presentation of neuropsychiatrie lupus erythematosus. Binocul Vis Strabismus Q 2003; 18:29-30.
71. Galindo M, Pablos JL, Gomez-Reino JJ. Internuclear ophthalmoplegia in systemic lupus erythematosus. Semin Arthritis Rheum 1998; 28:179-186.
72. Cogen MS, Kline LB, Duvall ER. Bilateral internuclear ophthalmoplegia in systemic lupus erythematosus. J Clin Neuroophthalmol 1987; 7:69-73.
73. Jackson G, Miller M, Littlejohn G, et al. Bilateral internuclear ophthalmoplegia in systemic lupus erythematosus. J Rheumatol 1986; 13:1161-1162.
74. Meyer MW, Wild JH. Letter: Unilateral internuclear ophthalmoplegia in systemic lupus erythematosus. Arch Neurol 1975; 32:486.
75. Brandt KD, Lesseil S, Cohen AS. Cerebral disorders of vision in systemic lupus erythematosus. Ann Intern Med 1975; 83:163-169.
76. Read RW, Weiss AH, Sherry DD. Episcleritis in childhood. Ophthalmology 1999; 106:2377-2379.
77. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology 1995; 102:687-692.
78. Hakin KN, Watson PG. Systemic associations of scleritis. Int Ophthalmol Clin 1991; 31:111-129.
79. Frith P, Burge SM, Millard PR, et al. External ocular findings in lupus erythematosus: a clinical and immunopathological study. Br J Ophthalmol 1990; 74:163-167.
80. Heiligenhaus A, Dutt JE, Foster CS. Histology and immunopathology of systemic lupus erythematosus affecting the conjunctiva. Eye 1996; 10 (Pt 4):425-432.
81. Pavesio CE, Meier FM. Systemic disorders associated with episcleritis and scleritis. Curr Opin Ophthalmol 2001; 12:471-478.
82. Acharya N, Pineda R 2nd, Uy HS, et al. Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis. Ophthalmology 2005; 112:e19-e23.
83. Donzis PB, Insler MS, Buntin DM, et al. Discoid lupus erythematosus involving the eyelids. Am J Ophthalmol 1984; 98:32-36.
84. Ena P, Pinna A, Carta F. Discoid lupus erythematosus of the eyelids associated with staphylococcal blepharitis and Meibomian gland dysfunction. Clin Exp Dermatol 2006; 31:77-79.
85. Huey C, Jakobiec FA, Iwamoto T, et al. Discoid lupus erythematosus of the eyelids. Ophthalmology 1983; 90:1389-1398.
86. Koga M, Kubota Y, Kiryu H, et al. A case of discoid lupus erythematosus of the eyelid. J Dermatol 2006; 33:368-371.
87. Lee CW, Sung YK, Bae SC. An unusual form of cutaneous lupus erythematosus over the eyelid in systemic lupus erythematosus. Lupus 2005; 14:564-565.
88. Mseddi M, Marrekchi S, Meziou TJ, et al. Discoid lupus erythematosus with eyelid involvement: a series of nine patients. J Fr Ophtalmol 2007; 30:247-249.
89. Gunasekera V, Jayaram H, Kashani S, et al. Refractory discoid lupus erythematosis of the eyelid successfully treated with intra-lesional triamcinolone. Eye 2008 [Epub ahead of print].
90. Serop S, Vianna RN, Claeys M, et al. Orbital myositis secondary to systemic lupus erythematosus. Acta Ophthalmol (Copenh) 1994; 72:520-523.
91. Arthurs BP, Khalil MK, Chagnon F, et al. Orbital infarction and melting in a patient with systemic lupus erythematosus. Ophthalmology 1999; 106:2387-2390.
92. Smith CA, Pinals RS. Periorbital edema in systemic lupus erythematosus. Arch Intern Med 1982; 142:1711-1712.
93. Norden D, Weinberg J, Schumacher HR, et al. Bilateral periorbital edema in systemic lupus erythematosus. J Rheumatol 1993; 20:2158-2160.
94. Amirlak I, Narchi H. Isolated orbital pseudotumor as the presenting sign of systemic lupus erythematosus. J Pediatr Ophthalmol Strabismus 2008; 45:51-54.
95. Bankhurst AD, Carlow TJ, Reidy RW. Exophthalmos in systemic lupus erythematosus. Ann Ophthalmol 1984; 16:669-671.
96. Feinfield RE, Hesse RJ, Rosenberg SA. Orbital inflammatory disease associated with systemic lupus erythematosus. South Med J 1991; 84:98-99.
97. Gomez-Puerta JA, Levy S, Khamashta MA, et al. Periorbital oedema in systemic lupus erythematosus. Lupus 2003; 12:866-869.
98. Grimson BS, Simons KB. Orbital inflammation, myositis, and systemic lupus erythematosus. Arch Ophthalmol 1983; 101:736-738.
99. Jordan DR, McDonald H, Olberg B, et al. Orbital panniculitis as the initial manifestation of systemic lupus erythematosus. Ophthal Plast Reconstr Surg 1993; 9:71-75.
100. Siebert S, Srinivasan U. Proptosis can be the presenting feature of systemic lupus erythematosus. Ann Rheum Dis 2004; 63:908-909.
101. Stavrou P, Murray PI, Batta K, et al. Acute ocular ischaemia and orbital inflammation associated with systemic lupus erythematosus. Br J Ophthalmol 2002; 86:474-475.
102. Easterbrook M. Ocular effects and safety of antimalarial agents. Am J Med 1988; 85 (4A):23-29.
103. Mavrikakis M, Papazoglou S, Sfikakis PP, et al. Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis 1996; 55:187-189.
104. Hollander DA, Aldave AJ. Drug-induced corneal complications. Curr Opin Ophthalmol 2004; 15:541-548.